Search

Cancer–tumor growth is a complex process depending on several biological factors, such as the chemical microenvironment of the tumor, the cellular metabolic profile, and its proliferation rate. Several mathematical models have been developed for identifying the interactions between tumor cells and tissue microenvironment, since they play an important role in tumor formation and progression. Toward this direction we propose a new continuum model of avascular glioma-tumor growth, which incorporates a new factor, namely, the glycolytic potential of cancer cells, to express the interactions of three different tumor-cell populations (proliferative, hypoxic, and necrotic) with their tissue microenvironment. The glycolytic potential engages three vital nutrients, i.e., oxygen, glucose, and lactate, which provide cells with the necessary energy for their survival and proliferation. Extensive simulations are performed for different evolution times and various proliferation rates, in order to investigate how the tumor growth is affected. According to medical experts, the experimental observations indicate that the model predicts quite satisfactorily the overall tumor growth as well as the expansion of each region separately. Following extensive evaluation, the proposed model may provide an essential tool for patient-specific tumor simulation and reliable prediction of glioma spatiotemporal expansion. [ABSTRACT FROM PUBLISHER]

Glioma is one of the most aggressive types of brain tumor. Several mathematical models have been developed during the past two decades, toward simulating the mechanisms that govern the development of glioma. The most common models use the diffusion–reaction equation (DRE) for simulating the spatiotemporal variation of tumor cell concentration. Nevertheless, despite the applications presented, there has been little work on studying the details of the mathematical solution and implementation of the 3-D diffusion model and presenting a qualitative analysis of the algorithmic results. This paper presents a complete mathematical framework on the solution of the DRE using different numerical schemes. This framework takes into account all characteristics of the latest models, such as brain tissue heterogeneity, anisotropic tumor cell migration, chemotherapy, and resection modeling. The different numerical schemes presented have been evaluated based upon the degree to which the DRE exact solution is approximated. Experiments have been conducted both on real datasets and a test case for which there is a known algebraic expression of the solution. Thus, it is possible to calculate the accuracy of the different models. [ABSTRACT FROM PUBLISHER]

Applying diffusive models for simulating the spatiotemporal change of concentration of tumour cells is a modern application of predictive oncology. Diffusive models are used for modelling glioblastoma, the most aggressive type of glioma. This paper presents the results of applying a linear quadratic model for simulating the effects of radiotherapy on an advanced diffusive glioma model. This diffusive model takes into consideration the heterogeneous velocity of glioma in gray and white matter and the anisotropic migration of tumor cells, which is facilitated along white fibers. This work uses normal brain atlases for extracting the proportions of white and gray matter and the diffusion tensors used for anisotropy. The paper also presents the results of applying this glioma model on real clinical datasets. [ABSTRACT FROM AUTHOR]

An increasing number of studies have profiled gene expressions in tumor specimens using distinct microarray platforms and analysis techniques. One challenging task is to develop robust statistical models in order to integrate multi-platform findings. We compare some methodologies on the field with respect to estrogen receptor (ER) status, and focus on a unified-among-platforms scale implemented by Shen et al. in 2004, which is based on a Bayesian mixture model. Under this scale, we study the ER intensity similarities between four breast cancer datasets derived from various platforms. We evaluate our results with an independent dataset in terms of ER sample classification, given the derived gene ER signatures of the integrated data. We found that integrated multi-platform gene signatures and fold-change variability similarities between different platform measurements can assist the statistical analysis of independent microarray datasets in terms of ER classification. [ABSTRACT FROM AUTHOR]

Abstract: The increased power and resolution capabilities of 3T Magnetic Resonance (MR) scanners have extended the reach of Magnetic Resonance Spectroscopy as a non-invasive diagnostic tool. Practical sensor calibration issues, magnetic field homogeneity effects and measurement noise introduce distortion into the obtained spectra. Therefore, a combination of robust preprocessing models and nonlinear pattern analysis algorithms is needed in order to evaluate and map the underlying relations of the measured metabolites. The aim of this work is threefold. Firstly we propose the use of a paired support vector machine kernel utilizing metabolic data from both affected and normal voxels in the patient''s brain for lesion classification problem. Secondly we quantify the performance of an optimal reduced feature set based on targeted CSI-144 scans in order to further reduce the data volume required for a reliable computed aided diagnosis. Thirdly we expand our previous formulation to full multiclass classification. The long term aim remains to provide the human expert with an easily interpretable system to assist clinicians with the time, volume and accuracy demanding diagnostic process. [Copyright &y& Elsevier]

The concept of gene signature overlap has been addressed previously in a number of research papers. A common conclusion is the absence of significant overlap. In this paper, we verify the aforementioned fact, but we also assess the issue of similarities not on the gene level, but on the biology level hidden underneath a given signature. We proceed by taking into account the biological knowledge that exists among different signatures, and use it as a means of integrating them and refining their statistical significance on the datasets. In this form, by integrating biological knowledge with information stemming from data distributions, we derive a unified signature that is significantly improved over its predecessors in terms of performance and robustness. Our motive behind this approach is to assess the problem of evaluating different signatures not in a competitive but rather in a complementary manner, where one is treated as a pool of knowledge contributing to a global and unified solution. [ABSTRACT FROM AUTHOR]

Abstract: Objective: The problem of marker selection in DNA microarray analysis has been addressed so far by two basic types of approaches, the so-called filter and wrapper methods. Wrapper methods operate in a recursive fashion where feature (gene) weights are re-evaluated and dynamically changing from iteration to iteration, while in filter methods feature weights remain fixed. Our objective in this study is to show that the application of filter criteria in a recursive fashion, where weights are potentially adjusted from cycle to cycle, produces noticeable improvement on the generalization performance measured on independent test sets. Methods and materials: Toward this direction we explore the behavior of two well known and broadly accepted pattern recognition approaches namely the support vector machines (SVM) and a single linear neuron (LN), properly adapted to the problem of marker selection. Within this context we also show how the kernel ability of SVM could be employed in a practical manner to provide alternative ways to approach the problem of reliable marker selection. Results: We explore how the proposed approaches behave in two application domains (breast cancer and leukemia), achieving comparable or even better results than those reported in the related bibliography. An important advantage of these approaches is their ability to derive stable performance without deteriorating due to the complexity of the application domain. Validation is performed using internal leave one out (ILOO) and 10-fold cross validation as well as independent test set evaluation. Conclusions: Results show that the proposed methodologies achieve remarkable performance and indicate that applying filter criteria in a wrapper fashion (‘wrapper filtering criteria’) provides a useful tool for marker selection. The contribution of this study is threefold. First it provides a methodology to apply filter criteria in a wrapper way (which is a new approach), second it introduces a fundamental pattern recognition component namely the single neuron (which is a linear estimator) and explores its behavior on marker selection and third it demonstrates an approach to exploit the kernel ability of SVMs in a practical and effective manner. [Copyright &y& Elsevier]

Abstract: Objective: The problem of gene selection has been extensively studied in a number of scientific works using various kinds of methods. However, the application of a linear neuron is a novel approach possessing several advantages. In this work we propose to study the behavior of such a linear neuron, appropriately adapted and trained to the problem of gene selection in the DNA microarray experiment. Methods and materials: We explore the proposed approach in terms of an accuracy evaluation criterion, which is used to assess the performance of the proposed methodology, but we also evaluate the produced results in terms of cluster quality and survival prediction. Cluster quality reflects the ability of the method to select differentially expressed genes, which in turn leads to better clustering and survival prediction. Results: We directly compare the proposed methodology with RFE-SVM, a well known and broadly accepted method demonstrating remarkable performance on various data sets of clinical interest. Conclusions: Conducted computational experiments show that the proposed approach can be efficiently used within the field of gene selection producing high-quality results in terms of accuracy and robustness. [Copyright &y& Elsevier]

Automated algorithms are developed in this paper based on digital signal processing to correlate electron-optical data from skin collagen fibrils with known sequence data. In particular, they detect alterations on the ratio of major collagen types in skin upon age. [Copyright &y& Elsevier]

Personality is the characteristic set of an individual's behavioral and emotional patterns that evolve from biological and environmental factors. The recognition of personality profiles is crucial in making human–computer interaction (HCI) applications realistic, more focused, and user friendly. The ability to recognize personality using neuroscientific data underpins the neurobiological basis of personality. This paper aims to automatically recognize personality, combining scalp electroencephalogram (EEG) and machine learning techniques. As the resting state EEG has not so far been proven efficient for predicting personality, we used EEG recordings elicited during emotion processing. This study was based on data from the AMIGOS dataset reflecting the response of 37 healthy participants. Brain networks and graph theoretical parameters were extracted from cleaned EEG signals, while each trait score was dichotomized into low- and high-level using the k-means algorithm. A feature selection algorithm was used afterwards to reduce the feature-set size to the best 10 features to describe each trait separately. Support vector machines (SVM) were finally employed to classify each instance. Our method achieved a classification accuracy of 83.8% for extraversion, 86.5% for agreeableness, 83.8% for conscientiousness, 83.8% for neuroticism, and 73% for openness. [ABSTRACT FROM AUTHOR]

Background: Circulating tumor cells (CTCs) are important for metastatic dissemination of cancer. They can provide useful information, regarding biological features and tumor heterogeneity; however, their detection and characterization are difficult due to their limited number in the bloodstream and their mesenchymal characteristics. Therefore, new biomarkers are needed to address these questions.Methods: Bioinformatics functional enrichment analysis revealed a subgroup of 24 genes, potentially overexpressed in CTCs. Among these genes, the chemokine receptor CXCR4 plays a central role. After prioritization according to the CXCR4 corresponding pathways, five molecules (JUNB, YWHAB, TYROBP, NFYA, and PRDX1) were selected for further analysis in biological samples. The SKBR3, MDA-MB231, and MCF7 cell lines, as well as PBMCs from normal (n = 10) blood donors, were used as controls to define the expression pattern of all the examined molecules. Consequently, 100 previously untreated metastatic breast cancer (mBC) patients (n = 100) were analyzed using the following combinations of antibodies: CK (cytokeratin)/CXCR4/JUNB, CK/NFYA/ΥWHΑΒ (14-3-3), and CK/TYROBP/PRDX1. A threshold value for every molecule was considered the mean expression in normal PBMCs.Results: Quantification of CXCR4 revealed overexpression of the receptor in SKBR3 and in CTCs, following the subsequent scale (SKBR3>CTCs>Hela>MCF7>MDA-MB231). JUNB was also overexpressed in CTCs (SKBR3>CTCs>MCF7>MDA-MB231>Hela). According to the defined threshold for each molecule, CXCR4-positive CTCs were identified in 90% of the patients with detectable tumor cells in their blood. In addition, 65%, 75%, 14.3%, and 12.5% of the patients harbored JUNB-, TYROBP-, NFYA-, and PRDX-positive CTCs, respectively. Conversely, none of the patients revealed YWHAB-positive CTCs. Interestingly, JUNB expression in CTCs was phenotypically and statistically enhanced compared to patients' blood cells (p = 0.002) providing a possible new biomarker for CTCs. Furthermore, the detection of JUNB-positive CTCs in patients was associated with poorer PFS (p = 0.015) and OS (p = 0.002). Moreover, JUNB staining of 11 primary and 4 metastatic tumors from the same cohort of patients revealed a dramatic increase of JUNB expression in metastasis.Conclusions: CXCR4, JUNB, and TYROBP were overexpressed in CTCs, but only the expression of JUNB was associated with poor prognosis, providing a new biomarker and a potential therapeutic target for the elimination of CTCs. [ABSTRACT FROM AUTHOR]